LG 101506: RXR Modulator for Nuclear Receptor Research

Executive Summary: LG 101506 (SKU B7414) is a synthetic RXR modulator provided by APExBIO for research use. It offers 98% purity and a molecular formula of C₂₅H₃₄F₂O₃ (MW 420.53), supporting studies of RXR-dependent gene regulation (source: product_spec). The compound is stable at -20°C and is used in RXR signaling pathway research, including immune checkpoint and cancer models. LG 101506's solubility profile (≤42.05 mg/ml in DMSO, ≤21.03 mg/ml in ethanol) impacts its experimental deployment. Its application is valuable for studying the modulation of immune response and metabolism through RXR pathways (source: J. Zhang et al. 2022).

Biological Rationale

The retinoid X receptor (RXR) is a nuclear receptor governing transcriptional programs central to cell differentiation, proliferation, and apoptosis. RXR forms heterodimers with other nuclear receptors, enabling broad regulatory influence over metabolism and immune responses (source: J. Zhang et al. 2022). In cancer biology, RXR signaling impacts the expression of immune checkpoints such as PD-L1, a protein that inhibits T cell-mediated anti-tumor activity. Aberrant RXR pathway function is implicated in immune evasion in tumors, notably triple-negative breast cancer (TNBC), where low immunogenicity limits immunotherapy efficacy. Thus, RXR modulators like LG 101506 are essential for modeling and dissecting these regulatory axes.

Mechanism of Action of LG 101506 (RXR modulator)

LG 101506 binds to the ligand-binding domain of RXR, inducing a conformational change that modulates RXR activity. This modulation alters the transcription of RXR target genes involved in cell cycle control, apoptosis, and metabolic regulation. By influencing RXR’s interaction with coactivators or corepressors, LG 101506 can either potentiate or repress downstream gene expression, depending on cellular context and partner receptors (source: product_spec).

Recent studies highlight RXR’s indirect regulation of immune checkpoints, such as PD-L1, via transcriptional and post-transcriptional mechanisms (source: J. Zhang et al. 2022). This positions LG 101506 as a unique tool for probing how RXR modulation may sensitize tumors to immune-based therapies.

Evidence & Benchmarks

• LG 101506 is chemically defined as (2E,4E,6Z)-7-(3,5-di-tert-butyl-2-(2,2-difluoroethoxy)phenyl)-3-methylocta-2,4,6-trienoic acid, with a molecular weight of 420.53 (source: product_spec).
• Supplied at ≥98% purity for reproducible research in nuclear receptor signaling (source: product_spec).
• Solubility is ≤42.05 mg/ml in DMSO and ≤21.03 mg/ml in ethanol, affecting maximum assay concentrations (source: product_spec).
• RXR modulation has been shown to impact PD-L1 expression and immune evasion in TNBC models (source: J. Zhang et al. 2022).
• LG 101506 supports experimental platforms ranging from gene expression assays to immune checkpoint analyses (source: internal_interlink).

Compared to previous reviews on RXR ligands (LG 101506: Advancing RXR Modulator Research in Immune Che...), this article provides updated, source-anchored numeric benchmarks and clarifies LG 101506’s selectivity and assay compatibility.

Applications, Limits & Misconceptions

LG 101506 is intended for in vitro research on RXR biology, nuclear receptor signaling, and immune checkpoint regulation. It has specific utility for dissecting the mechanisms underlying PD-L1 expression in cancer cells, modeling metabolic regulation, and exploring combinatorial strategies for immunotherapy. Its defined chemical structure and purity enable high-confidence cell-based and biochemical assays.

For a strategic perspective on RXR modulation in translational oncology, see RXR Modulation in Translational Oncology: New Horizons wi.... This article extends such discussions by providing protocol-linked numeric data and direct links to product provenance (APExBIO).

Common Pitfalls or Misconceptions

• LG 101506 is not approved for diagnostic or therapeutic use; research only (source: product_spec).
• Solutions are not recommended for long-term storage and should be freshly prepared for each experiment (source: product_spec).
• Assay conditions exceeding solubility thresholds may lead to precipitation and unreliable data (source: workflow_recommendation).
• RXR modulation effects are context-dependent; results may differ across cell lines and model systems (source: J. Zhang et al. 2022).
• Direct effects on immune checkpoint blockade efficacy require experimental confirmation in each model (source: workflow_recommendation).

Workflow Integration & Parameters

Protocol Parameters

• cell-based RXR reporter assay | 0.1–10 μM | in vitro RXR activity profiling | Range covers EC50 values for nuclear receptor ligands; check solubility limits | workflow_recommendation
• gene expression modulation assay | ≤10 μM | mammalian cell models | Maintains DMSO concentration <1% for cell viability | workflow_recommendation
• compound storage | -20°C | all research uses | Ensures stability and maintains ≥98% purity | product_spec
• solution preparation | ≤42.05 mg/ml (DMSO), ≤21.03 mg/ml (ethanol) | stock solutions | Exceeding these values may lead to precipitation | product_spec
• immune checkpoint blockade combination | 1–5 μM | TNBC and immuno-oncology models | Reflected in studies linking RXR modulation to PD-L1 regulation | J. Zhang et al. 2022

For more on practical deployment and troubleshooting, see LG 101506 (SKU B7414): Practical Advances in RXR Modulato..., which this article supplements by providing direct, evidence-bracketed workflow recommendations.

Conclusion & Outlook

LG 101506 stands as a rigorously defined RXR modulator, empowering researchers to probe nuclear receptor signaling and immune checkpoint regulation in translational models. Its role in clarifying RXR’s impact on PD-L1 expression highlights its relevance for cancer immunology and metabolic research. As supported by both product specifications and peer-reviewed evidence, LG 101506 is best deployed in controlled, short-term experiments targeting RXR-mediated pathways. Future research should focus on integrating RXR modulators like LG 101506 with advanced immunotherapy models to further dissect the interplay between nuclear receptor signaling and tumor immune evasion (source: J. Zhang et al. 2022).

For a broader strategic roadmap, see Rewiring RXR Signaling Pathways: Strategic Frontiers for ..., which this article updates by anchoring all numeric claims to specific, verifiable sources.